05B4 Savage, Michael - Thomas Jefferson University
Thomas Jefferson University
Sidney Kimmel Medical College
Department of Medicine

Savage, Michael

< Back



Michael P. Savage, MD

Contact Dr. Savage

925 Chestnut Street
Mezzanine Level
Philadelphia, PA 19107

(215) 955-4474
(215) 503-5650 fax

Medical School

Jefferson Medical College - 1980


New England Deaconess Hospital - Harvard


Thomas Jefferson University Hospital

Board Certification

Internal Medicine
Cardiovascular Disease
Interventional Cardiology

Hospital Appointment

Thomas Jefferson University Hospital


Most Recent Peer-Reviewed Publications

  1. A call to arms: Radial artery access for percutaneous coronary intervention
  2. Primary stroke in a woman with sickle cell anemia responsive to hydroxyurea therapy
  3. "very" very late stent thrombosis: Acute myocardial infarction from drug-eluting stent thrombosis more than 5 years after implantation
  4. Renal denervation revisited: Complexity following symplicity
  5. Imaging of adult atrial septal defects with CT angiography
  6. Safety, effectiveness, and outcomes of cardiac catheterization in nonagenarians
  7. Coronary slow flow phenomenon: More than just an angiographic curiosity
  8. Management of clopidogrel hypersensitivity without drug interruption
  9. Advances in vein graft inte 2238 rvention
  10. Clopidogrel hypersensitivity: Clinical challenges and options for management
  11. Decision Analytic Model for Evaluation of Suspected Coronary Disease with Stress Testing and Coronary CT Angiography
  12. Cost-effectiveness of coronary CT angiography in evaluation of patients without symptoms who have positive stress test results
  13. Accuracy of MDCT in assessing the degree of stenosis caused by calcified coronary artery plaques
  14. Rebuttal: Rotaglide rescue
  15. Facilitated stent delivery using applied topical lubrication
  16. Subepicardial aneurysm with impending cardiac rupture: A case of antemortem diagnosis and review of the literature
  17. Efficacy of intracoronary nicardipine in the treatment of no-reflow during percutaneous coronary intervention
  18. Nine-month outcome of patients treated by percutaneous coronary interventions for bifurcation lesions in the recent era: A report from the prevention of restenosis with tranilast and its outcomes (PRESTO) trial
  19. Stenting advances mean that clinical outcomes are maintained, but procedural costs are reduced in the absence of predilatation
  20. Debulking does not benefit patients undergoing intracoronary beta-radiation therapy for in-stent restenosis: Insights from the start trial